Redhill Biopharma Ltd (NASDAQ:RDHL)

6.19
Delayed Data
As of 2:50pm ET
 -0.04 / -0.64%
Today’s Change
4.30
Today|||52-Week Range
11.25
+20.43%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Redhill Biopharma Ltd have a median target of 19.50, with a high estimate of 36.00 and a low estimate of 18.00. The median estimate represents a +215.02% increase from the last price of 6.19.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Redhill Biopharma Ltd. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.72
Sales
$1.9M
Reporting Date
Feb 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 20.02%
 
 
 
 
 
 
Growthannually -25.66%
 
 
 
 
 
 

Sales

Growthquarterly 25.84%
 
 
 
 
 
 
Growthannually 3,896.05%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.